August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
August 11, 2022
The University of Cincinnati's Joseph Broderick, MD, provided comments in a TCTMD article reviewing the results of a recent study that found administering the drug tirofiban before endovascular thrombectomy does not improve functional outcomes in patients.
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
August 12, 2022
The University of Cincinnati's Alberto Espay, MD, joined WVXU's Cincinnati Edition to discuss recent allegations that a key 2006 Alzheimer's study from the University of Minnesota may have been fabricated.
September 12, 2022
The University of Cincinnati's Thomas Herzog, MD, was featured on 55KRC radio's Simply Medicine program to discuss a recent study that found that metastatic, or advance stage, cervical cancer cases are increasing in the United States.
October 6, 2022
U.S. News & World Report highlighted recent research from the University of Cincinnati that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
October 17, 2022
Local media covered the 13th annual Walk Ahead for a Brain Tumor Cure event, which raised more than $200,000 for the UC Brain Tumor Center.
September 27, 2022
UC's Ann Brown, MD, and breast cancer survivor Michele Young talked with WLWT about House Bill 371, a new law that requires insurance companies to cover additional screenings for individuals who are at high risk for breast cancer or have dense breast tissue, going into effect.
October 5, 2022
The University of Cincinnati's Rifat Wahab, DO, joined WPFW's What's at Stake radio show and podcast to discuss Breast Cancer Awareness Month and racial disparities in breast cancer.
March 23, 2023
The University of Cincinnati's Erich J. Boomgarden, MD, provided expert analysis of a new Food and Drug Administration policy that will require health care providers to tell women if they have dense breast tissue, a change that could save lives.